- 908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
- 908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
- 908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
- 908 Devices to Participate in Upcoming Investor Conferences
- 908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
More ▼
Key statistics
As of last trade, 908 Devices Inc. (MASS:NMQ) traded at 5.56, 14.64% above the 52 week low of 4.85 set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.51 |
---|---|
High | 5.56 |
Low | 5.40 |
Bid | 5.35 |
Offer | 6.49 |
Previous close | 5.56 |
Average volume | 173.41k |
---|---|
Shares outstanding | 32.91m |
Free float | 30.39m |
P/E (TTM) | -- |
Market cap | 182.98m USD |
EPS (TTM) | -1.13 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼